Bio-Rad Laboratories, Inc.BIONYSE
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR-56.2%
5Y CAGR-53.9%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-56.2%/yr
Quarterly compound
5Y CAGR
-53.9%/yr
Consistent
Percentile
P64
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.52% |
| Q3 2025 | -0.55% |
| Q2 2025 | 12.84% |
| Q1 2025 | -10.50% |
| Q4 2024 | -3.93% |
| Q3 2024 | 0.22% |
| Q2 2024 | 8.78% |
| Q1 2024 | -10.78% |
| Q4 2023 | 9.00% |
| Q3 2023 | -7.39% |
| Q2 2023 | 0.02% |
| Q1 2023 | -8.73% |
| Q4 2022 | 6.23% |
| Q3 2022 | -5.60% |
| Q2 2022 | -1.65% |
| Q1 2022 | 0.41% |
| Q4 2021 | -8.33% |
| Q3 2021 | 8.92% |
| Q2 2021 | 0.24% |
| Q1 2021 | -12.94% |
| Q4 2020 | 25.28% |
| Q3 2020 | 25.37% |
| Q2 2020 | -7.68% |
| Q1 2020 | -3.96% |
| Q4 2019 | 7.63% |
| Q3 2019 | -0.24% |
| Q2 2019 | -1.28% |
| Q1 2019 | -6.60% |
| Q4 2018 | 16.41% |
| Q3 2018 | -4.96% |
| Q2 2018 | -0.18% |
| Q1 2018 | -11.01% |
| Q4 2017 | 11.52% |
| Q3 2017 | 11.42% |
| Q2 2017 | 1.23% |
| Q1 2017 | -14.11% |
| Q4 2016 | 12.48% |
| Q3 2016 | -0.27% |
| Q2 2016 | 6.14% |
| Q1 2016 | -14.42% |